Published in Cochrane Database Syst Rev on August 04, 2010
An Open Label Study of CM-AT for the Treatment of Children With Autism | NCT02649959
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) | NCT02410902
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berl) (2013) 1.47
Translational approaches to the biology of Autism: false dawn or a new era? Mol Psychiatry (2012) 1.26
Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics (2012) 1.20
Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells (2014) 1.20
The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. J Autism Dev Disord (2012) 1.19
Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges. Ann Gen Psychiatry (2012) 1.06
Focal brain inflammation and autism. J Neuroinflammation (2013) 1.03
Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach. J Autism Dev Disord (2015) 0.97
TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME. Res Autism Spectr Disord (2012) 0.94
High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Ann Epidemiol (2012) 0.94
Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder. Neurotherapeutics (2012) 0.91
MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res (2011) 0.89
Systematic review of the properties of tools used to measure outcomes in anxiety intervention studies for children with autism spectrum disorders. PLoS One (2014) 0.88
Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? J Biomed Biotechnol (2012) 0.85
Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism. Cereb Cortex (2014) 0.83
Defining treatment response and symptom remission for anxiety disorders in pediatric autism spectrum disorders using the Pediatric Anxiety Rating Scale. J Autism Dev Disord (2015) 0.82
Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults. Neuroimage Clin (2013) 0.81
Managing anxiety and depressive symptoms in adults with autism-spectrum disorders. J Psychiatry Neurosci (2011) 0.80
Perspectives on the use of stem cells for autism treatment. Stem Cells Int (2013) 0.80
Aripiprazole: a review of its use in the treatment of irritability associated with autistic disorder patients aged 6-17. J Cent Nerv Syst Dis (2011) 0.79
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability. Front Behav Neurosci (2015) 0.78
Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry (London) (2011) 0.78
Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis. Drugs Real World Outcomes (2016) 0.78
Aripiprazole Improved Obsessive Compulsive Symptoms in Asperger's Disorder. Clin Psychopharmacol Neurosci (2011) 0.77
ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings. Curr Top Behav Neurosci (2014) 0.75
Anxiety in youth with autism spectrum disorders: implications for treatment. Expert Rev Neurother (2015) 0.75
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial. Trials (2016) 0.75
Understanding stalking behaviors by individuals with Autism Spectrum Disorders and recommended prevention strategies for school settings. J Autism Dev Disord (2014) 0.75
Mental health of children in foster and kinship care in New South Wales, Australia. J Paediatr Child Health (2006) 2.81
Clinical management of deliberate self-harm in young people: the need for evidence-based approaches to reduce repetition. Aust N Z J Psychiatry (2005) 1.49
WITHDRAWN: Psychosocial and pharmacological treatments for deliberate self harm. Cochrane Database Syst Rev (2015) 1.41
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics (2008) 1.05
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2013) 0.95
Iron supplementation for breath-holding attacks in children. Cochrane Database Syst Rev (2010) 0.93
The Children's Attention Project: a community-based longitudinal study of children with ADHD and non-ADHD controls. BMC Psychiatry (2013) 0.90
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry (2004) 0.90
Interventions for increasing ankle range of motion in patients with neuromuscular disease. Cochrane Database Syst Rev (2010) 0.89
Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev (2015) 0.86
Clinical guidance on the use of antidepressant medications in children and adolescents. Aust Fam Physician (2005) 0.86
Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents. Cochrane Database Syst Rev (2012) 0.86
"Are you available for the next 18 months?" - methods and aims of a longitudinal birth cohort study investigating a universal developmental surveillance program: the 'Watch Me Grow' study. BMC Pediatr (2014) 0.85
Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev (2016) 0.85
Child maltreatment, subsequent non-suicidal self-injury and the mediating roles of dissociation, alexithymia and self-blame. Child Abuse Negl (2012) 0.83
Pharmacological interventions for self-harm in adults. Cochrane Database Syst Rev (2015) 0.81
Auditory integration training and other sound therapies for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2011) 0.81
The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder. Curr Opin Psychiatry (2011) 0.79
Does the treatment of mental disorders in childhood lead to a healthier adulthood? Curr Opin Psychiatry (2007) 0.78
Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2012) 0.78
Update on attention deficit hyperactivity disorder. J Paediatr Child Health (2010) 0.78
Family adjustment and parenting stress when an infant has serious liver disease: the Australian experience. J Pediatr Gastroenterol Nutr (2015) 0.77
Depression in children. BMJ (2002) 0.77
The study design and methodology for the ARCHER study--adolescent rural cohort study of hormones, health, education, environments and relationships. BMC Pediatr (2012) 0.77
Chelation therapy and autism. BMJ (2006) 0.77
Chelation for autism spectrum disorder (ASD). Cochrane Database Syst Rev (2015) 0.77
Comparison of diagnostic guidelines for juvenile bipolar disorder. Aust N Z J Psychiatry (2007) 0.77
Methodological issues associated with collecting sensitive information over the telephone--experience from an Australian non-suicidal self-injury (NSSI) prevalence study. BMC Med Res Methodol (2011) 0.76
Depression in adolescents. BMJ (2007) 0.76
Chelation for autism spectrum disorder (ASD). Cochrane Database Syst Rev (2015) 0.76
7. Language disorders and autism. Med J Aust (2005) 0.76
Sport is good, war is bad: discuss. Curr Opin Psychiatry (2012) 0.75
The 'youth model' in mental health services. Australas Psychiatry (2008) 0.75
Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism. Trials (2014) 0.75
Managing non-epileptic seizures and psychogenic dystonia in an adolescent girl with preterm brain injury. Harv Rev Psychiatry (2013) 0.75
Implementing guidance and guidelines for developing and delivering equitable child and adolescent mental health services. Curr Opin Psychiatry (2009) 0.75
Family Impact and Infant Emotional Outcomes Following Diagnosis of Serious Liver Disease or Transplantation in Infancy. J Pediatr Gastroenterol Nutr (2016) 0.75
Association Between Parenting Style and Social Outcomes in Children with and Without Attention-Deficit/Hyperactivity Disorder: An 18-Month Longitudinal Study. J Dev Behav Pediatr (2017) 0.75
Text messaging is a useful reminder tool. Arch Dis Child (2014) 0.75
Austerity, poverty, resilience, and the future of mental health services for children and adolescents. Curr Opin Psychiatry (2011) 0.75
Should clinicians engaged in delivering evidence-based child and adolescent mental healthcare be excited about findings from empirical research? Curr Opin Psychiatry (2010) 0.75